Kezar Life Sciences Inc. (NASDAQ: KZR) Stock Information | RedChip

Kezar Life Sciences Inc. (NASDAQ: KZR) Listen to this Section


$0.61
-0.0099 ( -1.59% ) 188.6K

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Market Data


Open


$0.61

Previous close


$0.62

Volume


188.6K

Market cap


$44.76M

Day range


$0.61 - $0.64

52 week range


$0.54 - $1.69

Insider Ownership Transactions

Total Amount Purchased: -3,500,000.00 | $ -2,151,450.00

Date Type Amount Purchased Purchaser
2023-08-17 Sale -3500000.00 Morningside Venture Investments Ltd

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 11 Jun 04, 2024
10-q Quarterly Reports 77 May 09, 2024
8-k 8K-related 12 May 09, 2024
def Proxies and info statements 17 Apr 26, 2024
ars Annual reports 1 Apr 26, 2024
pre Proxies and info statements 17 Apr 16, 2024
10-k Annual reports 96 Mar 14, 2024
8-k 8K-related 13 Mar 14, 2024
3 Insider transactions 2 Jan 17, 2024
4 Insider transactions 1 Jan 09, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.